Korro Bio (KRRO) Current Leases (2020 - 2026)

Korro Bio's Current Leases history runs 7 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• Quarterly Current Leases rose 21.47% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (up 21.47% YoY) and the FY2025 annual result came in at $2.7 million, up 108.1% from the prior year.
• Current Leases was $2.8 million for Q1 2026 at Korro Bio, up from $2.7 million in the prior quarter.
• Across five years, Current Leases topped out at $3.1 million in Q3 2025 and bottomed at $457000.0 in Q2 2024.
• A 5-year average of $2.0 million and a median of $2.0 million in 2023 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2024 — Current Leases tumbled 78.87% — and 2025, when it soared 430.63%.
• Korro Bio's Current Leases stood at $2.9 million in 2022, then sank by 31.84% to $2.0 million in 2023, then tumbled by 35.51% to $1.3 million in 2024, then surged by 108.1% to $2.7 million in 2025, then advanced by 4.83% to $2.8 million in 2026.
• Business Quant data shows KRRO's Current Leases at $2.8 million in Q1 2026, $2.7 million in Q4 2025, and $3.1 million in Q3 2025.